Fluad's Italian Problem Could Reduce Confidence In Vaccines Across Europe
This article was originally published in The Pink Sheet Daily
Executive Summary
The EMA has given Novartis’ flu vaccine Fluad the all-clear after serious safety concerns were raised in Italy, but the publicity around the drug could pressure an already burdened vaccines industry.